UBS Group’s Labcorp LH Stock Holding History

UBS Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200	Closed	-$57.4K	–	10899
2025 Q3	$57.4K	Hold	200	–	–	﹤0.01%	7469
2025 Q2	$52.5K	Hold	200	–	–	﹤0.01%	7727
2025 Q1	$46.5K	Buy	+200	New	+$48.5K	﹤0.01%	7647
2023 Q1	–	Sell	-116	Closed	-$23.5K	–	10014
2022 Q4	$23.5K	Sell	116 -117	-50%	-$22.9K	﹤0.01%	7482
2022 Q3	$41K	Buy	+233	New	+$47.7K	﹤0.01%	6544
2022 Q1	–	Sell	-233	Closed	-$63K	–	10612
2021 Q4	$63K	Buy	+233	New	+$57.7K	﹤0.01%	6707
2021 Q1	–	Sell	-116	Closed	-$20K	–	9264
2020 Q4	$20K	Sell	116 -8,265	-99%	-$1.43M	﹤0.01%	6944
2020 Q3	$1.36M	Buy	8,381 +8,265	+7,125%	+$1.31M	﹤0.01%	3414
2020 Q2	$17K	Sell	116 -8,381	-99%	-$1.16M	﹤0.01%	6659
2020 Q1	$923K	Buy	+8,497	New	+$1.22M	﹤0.01%	3418

Other funds holding LH

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

UBS Group's LH Position: Q3 2026 in Review

UBS Group reduced its Labcorp (LH) stake by 35% in Q3 2026, selling an estimated $55.9M and leaving 335,819 shares worth $103M. The position accounts for 0.01% of the portfolio, ranked #1074.

UBS Group first reported a position in LH in Q4 2014 and has held it in 48 quarters since. The position peaked at $151M in Q1 2026. 831 funds tracked by Wall St. Rank hold LH as of Q3 2026.

UBS Group held 335,819 shares of Labcorp worth $103M as of Q3 2026.
UBS Group sold 180,251 Labcorp shares in Q3 2026, an estimated $55.9M.
Labcorp made up 0.01% of UBS Group's portfolio in Q3 2026, its #1074 holding.
UBS Group first reported a position in Labcorp in Q4 2014 and has held it in 48 quarters since.
UBS Group's Labcorp position peaked at $151M in Q1 2026.
831 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.